Related Experiment Video
Updated: Dec 12, 2025
13:17
In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.8K
Baicalein: A metabolite with promising antineoplastic activity
Hardeep Singh Tuli1, Vaishali Aggarwal2, Jagjit Kaur3
1Department of Biotechnology, Maharishi Markandeshwar (Deemed to be University), Mullana-Ambala, Haryana 133207, India.
Life Sciences
|August 12, 2020
Summary
Baicalein, a natural compound, shows promising anti-cancer effects by targeting key signaling pathways. Pre-clinical studies suggest its potential as an adjunct therapy to chemotherapy, addressing cancer cell heterogeneity and drug resistance.
Area of Science:
- Oncology
- Natural Products Chemistry
Background:
- Cancer cell heterogeneity drives variable treatment responses and drug resistance.
- Natural compounds are being investigated as complementary cancer therapies.
Purpose of the Study:
- To review the chemistry and anti-cancer mechanisms of baicalein.
- To highlight baicalein's potential as an adjunct cancer treatment.
Main Methods:
- Review of pre-clinical trial data on baicalein's anti-cancer effects.
- Analysis of baicalein's impact on key signaling pathways.
Main Results:
- Baicalein exhibits anti-inflammatory, anti-angiogenic, and anti-metastatic properties.
- Baicalein modulates signaling pathways including MAPK, mTOR, AKT, PARP, MMPs, and caspases.
Conclusions:
- Baicalein demonstrates significant anti-malignant potential.
- Baicalein warrants further investigation as an adjunct therapy for cancer treatment.
